Search - tctmd.com

Displaying 441 - 460 of 521

Sort: Relevancy | Date

News Industry News

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

November 09, 2011

News Industry News

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

November 09, 2011

News Industry News

New analysis measures cost effectiveness of transcatheter aortic valve replacement compared to surgical valve replacement

November 09, 2011

News Industry News

MAQUET Cardiovascular Announces FDA 510(k) Clearance and CE Mark for the Cardiosave Intra-Aortic Balloon Pump

November 09, 2011

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Industry News

CUMC Expert Raises Concerns about Heart Disease Trends

November 09, 2011

News Industry News

Coronary Thrombectomy in conjunction with primary percutaneous coronary intervention in patients with high thrombotic burden improves myocardial perfusion

November 09, 2011

News Industry News

Clinical trial that compared transapical transcatheter aortic valve replacement to surgical aortic valve replacement

November 09, 2011

News Industry News

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

November 09, 2011

News Industry News

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

November 09, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Industry News

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

November 08, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Industry News

InSeal Medical Announces Patients Successfully Treated with Novel Intravascular Large Bore Puncture Closure Device

November 08, 2011

News Industry News

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

November 08, 2011

Advertisement

PARTNER QoL data hint transapical TAVI falls short of aortic-valve surgery

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

New analysis measures cost effectiveness of transcatheter aortic valve replacement compared to surgical valve replacement

MAQUET Cardiovascular Announces FDA 510(k) Clearance and CE Mark for the Cardiosave Intra-Aortic Balloon Pump

Low CV Event Rate Prompts Closure of Prasugrel Trial

CUMC Expert Raises Concerns about Heart Disease Trends

Coronary Thrombectomy in conjunction with primary percutaneous coronary intervention in patients with high thrombotic burden improves myocardial perfusion

Clinical trial that compared transapical transcatheter aortic valve replacement to surgical aortic valve replacement

Clinical trial supports radial artery access as preferable to femoral artery for angioplasty

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

InSeal Medical Announces Patients Successfully Treated with Novel Intravascular Large Bore Puncture Closure Device

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content